History

• 2024

  • Jan.

    Certification of INNO-BIZ

• 2023

  • Sep.

    Selected in R&D Strategy Master Plan supporting, national R&D project

  • Aug.

    Korean Good Company Award (metabolic anti-cancer drug)

  • May.

    Selected in Industry-Academic collaboR&D supporting program, national R&D project

  • Apr.

    Selected in K-start up investment roadshow companies (Boston, US)

  • Mar.

    Start of CLS-S1 process development and pre-clinical test

  • Feb.

    Selected for national projects Next-generated R&D Technical service support project

  • Feb.

    Selected in Next generation medical research promotion program of K-medi hub, national R&D project

  • Jan.

    Start of CLS-S3 process development and pre-clinical test

• 2022

  • Dec.

    Selected in pre-clinical supporting program of K-Medihub, national R&D project
    2022 revenue achieved 7.88B KRW

  • Nov.

    Patent application of CLS-A1 (PCT)

  • Oct.

    Selected in K-UNICORN 200 Project (Baby Unicorn), national R&D project

  • Sep.

    Selected in TIPS-related global marketing program, national R&D project
    Start of CLS-A1 process development
    Patent application of CLS-S1 (KR)

  • Aug.

    Selected in Korea Drug Development Fund (KDDF) program, national R&D project

  • Jul.

    Completment of CLS-S3 Lead compound development

  • Jun.

    Completment of CLS-S1 Lead compound development

  • May.

    Series A Bridge Funding 0.8B KRW

  • Apr.

    Selected in Business supporting program of Biohealth Innovation Start-up Center, national R&D project

  • Mar.

    Selected in Bio industrial complex sales project of MAGOK district
    CLS-A1 humanization complete

  • Jan.

    MOU with Portray Ltd.

• 2021

  • Dec.

    Selected in TIPS-related business commerciallization program, national R&D project

  • Nov.

    MOU with Patheon for CDMO business
    Completment of CLS-S3 HIT compound development
    Certification of ISO9001 and ISO13485
    Patent application of CLS-A1 (KR)

  • Oct.

    Completment of CLS-S3 HIT compound development
    Establishment of cellus Australia Pty. (Queensland, Brisbane)

  • Jul.

    Series A Funding 2.4B KRW

  • Jun.

    Selected in startup R&D supporting program, national R&D project
    Selected in TIPS (Tech Incubator Program for startup) program, national R&D project

  • Apr.

    Establishment of Industrial R&D Center

• 2020

  • Oct.

    Seed Funding 1.2B KRW
    Certification of SME's and Startups

  • Aug.

    Established of Cellus Inc. (Aug. 24th)